The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes

Clinical trial NCT00044148 · COMPLETED

Trial details

NCT number: NCT00044148
Sponsor: Chromaderm, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2002-07-16
Primary completion: 2004-04-28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.